Related Experiment Video
Updated: Jun 17, 2026
08:27
Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Nutrigenetics/Nutrigenomics
1The Center for Genetics, Nutrition and Health, Washington, DC 20009, USA. cgnh@bellatlantic.net
Annual Review of Public Health
|January 15, 2010
Summary
Genetic predisposition influences all diseases. Integrating genetic and nutrient data through nutrigenetics is key for personalized nutrition and disease prevention strategies.
Area of Science:
- Genetics
- Nutrition Science
- Public Health
Background:
- Complex diseases have a genetic basis, increasingly identified through Genome-Wide Association Studies (GWASs).
- Essential nutrient information is often lacking in genetic studies, hindering personalized dietary recommendations.
- Nutrigenetics and nutrigenomics explore gene-nutrient interactions crucial for health and disease management.
Purpose of the Study:
- To highlight the need for integrating genetic and nutrient data for disease prevention.
- To emphasize the role of nutrigenetics/nutrigenomics in personalized nutrition.
- To propose a framework for evaluating gene-nutrient-disease associations for public health applications.
Main Methods:
- Review of current understanding of genetic predisposition in diseases.
- Analysis of the role of Genome-Wide Association Studies (GWASs).
- Examination of data from nutrigenetics and nutrigenomics research.
Main Results:
- Genome-Wide Association Studies (GWASs) identify genetic variants linked to complex diseases.
- Nutrigenetics/nutrigenomics studies reveal mechanisms of nutrient-gene interactions.
- A gap exists in incorporating nutrient information into genetic disease research.
Conclusions:
- Personalized nutrition requires understanding gene-nutrient interactions.
- A systematic process is needed to translate genetic and nutrient findings into public health strategies.
- Integrating genetic and nutritional data is vital for effective disease prevention and management.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...